Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MM-141 |
Trade Name | |
Synonyms | Istiratumab |
Drug Descriptions |
Istiratumab (MM-141) is a monoclonal antibody, which binds to human epidermal growth factor receptor B3 (ERBB3) and the human insulin-like growth factor-1 receptor (IGF-1R), blocking ligand binding and preventing activation of PI3K/AKT signaling (PMID: 24282274, PMID: 31912800). |
DrugClasses | HER3 (ERBB3) Antibody 23 IGF1R Antibody 8 |
CAS Registry Number | 1509928-04-4 |
NCIT ID | C103863 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Everolimus + MM-141 | Everolimus MM-141 | 0 | 1 |
Gemcitabine + MM-141 + Nab-paclitaxel | Gemcitabine MM-141 Nab-paclitaxel | 0 | 1 |
MM-141 | MM-141 | 0 | 2 |